Boston Scientific Corp. said Monday it would pay Johnson & Johnson a hefty $1.73 billion to end more disputes in long-running legal battles over patents for heart stents.
The deal clears away some major legal exposure for Boston Scientific, but it carries a surprisingly large price tag that could reduce the company's ability to make deals to bolster its product pipeline and spur sales growth. Monday's announcement follows $716 million Boston Scientific paid to J&J following a settlement in September on 14 other patent-infringement suits.WSJ
No comments:
Post a Comment